[
    {
        "text": "what are your thoughts about estrogen therapy for women menopause and hormone therapies generally for women maybe even testosterone therapy you hear about that these days and then we'll talk about men so our practice is probably 70 30 male female so we have lots of women and this is a very important topic it's also probably let me think I just want to make sure I'm not being hyperbolic when I say this yep I don't think I am it's hands down the biggest screw-up of the entire medical field in the last 25 years now again it's possible in the next hour I'll think of nope there's a bigger screw up another another Giants yeah but but I don't think I will I I'm pretty confident that I won't be able to think of a bigger Act of incompetence then what happened with the Women's Health Initiative in the late 90s and early 2000s which is effectively the study that turned the entire medical field off hormone replacement therapy for women so it's important I think to explain what the study looked at so this was a study that was conducted in response to the widely held belief in the 70s and 80s that women should be placed on hormones as they're going through menopause right menopause is I guess maybe I'll even take a step back I don't know how much your audience is familiar with how estrogen progesterone work is it worth going into that stuff probably worth mentioning a bit of the top Contour some of them might be familiar with it we've done episodes on estrogen testosterone but frankly as I think back to those we didn't really go into the biology of estrogen testosterone enough yeah so I mean actually an interesting aside that I always tell my female patients who get a kick out of this um when you look at a woman's Labs",
        "start": "00:00:00",
        "duration": 216.93800000000005,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "you'll see her estrogen her progesterone her FSH her LH her testosterone her sexual binding Glide and all these things but based on the units they're reported in it's a very distorting picture of what the most common Androgen is in her body if you actually convert them to the same units she has much more testosterone in her body than estrogen interesting yeah I did not know that yeah then again I've never been a woman getting my hormone profile yeah yeah so even though a woman's testosterone is much less than a men uh than a man's level um it's still more than she has estrogen in her body wow so phenotypically right estrogen is the hormone that's dominating and test so it's the you know she has much higher estrogen than a man and much lower testosterone than a man but in absolute amounts she has more testosterone than estrogen just worth pointing that out incredible so um so so you know what what's happening to a woman from the age she starts menstruating until she goes through menopause outside of pregnancy and birth control and stuff like that is she has this cycle you know roughly every 28 days but it can vary where at the beginning of her period we call that day Zero her basic her estrogen and progesterone are very low you can't measure them and then what happens is the estrogen level starts to rise and it rises in response to a hormone called follicle stimulating hormone follicle stimulating hormone FSH that is getting her ready to ovulate and she ovulates at about the midpoint of her cycle so if we're just going to make the math easy on day 14 she's going to release a follicle from one of her ovaries and the estrogen level is sort of rising Rising Rising we love to measure hormones on day five because I want to have a standardized way in which I measure her hormones so our women know if we're in the business of trying to understand her",
        "start": "00:01:49",
        "duration": 211.20000000000002,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "hormones the day her period starts even if it's just a day of spotting that becomes our Benchmark and then day five I want to see every hormone on that day and if everything is going well I know what her FSH LH estradiol and progesterone should be on that day so the estrogen Rises starts to come down a little bit as she ovulates and then the luteinizing hormone kicks on because it's not going to prepare her uh uterus for uh the lining to accommodate a pregnancy so now you start to see estradiol go back but now for the first time progesterone goes up so progesterone has been doing nothing for 14 days and now it starts to rise and actually progesterone is the hormone that's dominating the second half which called her her luteal cycle so the first 14 days is the follicular cycle second is the luteal cycle so once you get to about the halfway point of that which is now just to do the math 21 days in the body has figured out if she's pregnant or not and again most of the time she's not going to be pregnant so the body says oh I don't need this lining that I've been preparing I'm going to shed it so now progesterone and estrogen start crashing and the lining is what is being shed and that is the menses by the way it's that last seven days of that cycle that in a susceptible woman is what creates those PMS symptoms so it's the actually this is something that you would probably have a better understanding of than me there is something about this in a susceptible woman where the enormous reduction of progesterone so quickly is probably impacting something in her brain so I think this is a this is a legitimate thing right I mean you know it's not like oh she's crazy because she's having all these PMS symptoms know we know that that's the case because if you put women on progesterone for those seven days those symptoms go away so if you can",
        "start": "00:03:34",
        "duration": 207.359,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "stabilize their progesterone during the last half of their ludial phase and sometimes we would just do it for the entire luteal phase just put them on a low dose of progesterone all PMS symptoms vanish very interesting I'll have to look up where the progesterone receptors are located in the brain the Allen brain Institute now has beautiful data of in-teacher hybridization which for books the donor says looking at RNA and so wear jeans and proteins ought to be expressed in the human brain by using actual human brain tissue sections as opposed to just mice so I'll take a look I think yeah what that progesterone emotionality link might be and where where it might exist neural circuit wise so then when the estrogen and progesterone reach their Nader again that starts the cycle so that just that cycle is happening over and over and over again Okay so it became you know well known in the 50s that okay a woman's gonna stop menstruating at some point her estrogen goes down why don't we just give her estrogen because that's clearly going to help with some of the symptoms of menopause so what what do women experience when they go through menopause the first symptoms are what are called vasomotor symptoms so this is usually in the form of night sweats hot flashes so and depending on the woman this can be really significant right these are women who can have a hard time sleeping they can be having hot flashes during the middle of the day they can wake up soaked in a pool of sweat um those tend to pass after a couple of years and then they get into sort of the more long-term complications of menopause so what we call vaginal atrophy vaginal dryness and then the stuff that we talked about a while ago which is the osteopenia osteoporosis uh a lot of women will complain of brain fog so",
        "start": "00:05:18",
        "duration": 207.12099999999998,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "I mean clearly this was an issue and it was recognized 70 years ago why don't we give women estrogen back to replace that hormone and so that went on for a couple of decades maybe less maybe a decade and then it was realized wait a minute we were driving up the risk of uterine cancer um and the reason for that is if you just give estrogen with no progesterone to antagonize it you will thicken the endometrium endlessly and you will increase the risk of hyperplasia well you'll you'll definitely undergo hyperplasia and then ultimately dysplasia dysplasia is pre-cancerous and ultimately we were seeing that so people figured out well actually if you want to give estrogen to a woman who still has her uterus you have to give her progesterone as well you have to be able to have a hormone to oppose the estrogen and then that became effectively in the 19 call it the 1970s ish the standard for um for HRT so in the early 1990s uh the NIH said look we haven't really studied this you know we have a ton of epidemiology that says giving women hormones seems to be doing really good things they feel better so they're all their symptoms go away they seem to have lower risk of heart disease lower risk of you know cardiovascular lower risk of cardiovascular these lower risk of bone fractures um everything seems to get better low risk of diabetes but we haven't tested this in a randomized prospective trial so let's do this so that became the Whi and it randomized it had two parallel arms so it had a group for women who did not have a uterus so these are women that had undergone hysterectomy for some other reason and then it had a group for women that did have their uterus in the",
        "start": "00:07:02",
        "duration": 224.22,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "first group there was a placebo arm and then an estrogen only arm and in the other group there was a progesterone plus estrogen versus a placebo everything about the way this study was done is a bit wonky some of it is justifiable but it's important to understand first the women were all way outside of menopause so none of these women were started when you would normally start HRT and um there were probably several reasons for that but one of them is and I think this is a legitimate reason they wanted hard outcomes they wanted to know death rates and if you're doing this on women in their 50s you just weren't going to get it right you couldn't wait too long yeah you got to wait too long and this was only going to be like a seven to ten year study so they had to do this on women who were much older they also disproportionately took much sicker women I believe the prevalence and again I'm going to get some of these numbers wrong and people are going to get all phosphorylated but you know I mean I'm in the ballpark right something like 30 40 of these women were smokers the prevalence of obesity diabetes was enormous so they they did they really disproportionately picked the most unhealthy population they could that was pretty advanced in age and again I think part of that was to say look we want to make sure that after seven years we really know if there's a difference in these causes of death um the other thing is this is kind of weird although again I I understand their rationale for it but this is a great example of be very careful when you look at a clinical trial that it remotely represents the patients you're interested in treating so they also treated no patients who were",
        "start": "00:08:53",
        "duration": 201.15900000000002,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "symptomatic the rationale being if we include in the study patients who are symptomatic those who are randomized to Placebo will drop out okay it makes sense in terms of study design makes no sense if the study design is um intended to mimic the real world that's right so now let's just keep track of the three issues we have a disproportionately unhealthy patient population who are not symptomatic and we're starting them more than 10 years after menopause the next thing that they did which again I understand why they did it but it's now the fourth strike against this study is and I've spoken with the pi of the study and asked this question Point Blank I'm actually going to have her on my podcast at some point soon to go over this in more detail is why did you use conjugated equine estrogen an MPA which is a synthetic form of progesterone horse yes estrogen horse it's horse urine it's like they collect horse urine so they're getting the it's it forces do urinate a lot or at least when they urinate it seems like a large volume of urine from what I've observed you have a lot of experience with this no but you know my sister rode horses for a little while my high school girlfriend had a horse and that thing I mean the the the peas were legendary it's a male horse yeah yeah so yeah so so the the conjugated equine estrogen is the estrogen that's collected from from female horses and then I'd say synthetic progesterone uh and I said to to uh to the person I said well why didn't you use what we use today which is bio-identical estrogen and progesterone like today when we put women on estrogen we use a it's an FDA product called The vivelle Dot so it's a patch that you just put on and it's estradiol but it's bioidentical estradiol and we use what's called micronized progesterone so bioidentical",
        "start": "00:10:36",
        "duration": 220.961,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "progesterone and she said well at the time we just wanted to test what was currently being used I said totally makes sense but again now you have four considerations that you have to keep in mind okay so despite those four considerations and I'm going to make a case for you why I think the mpa created a real problem in that study the synthetic progesterone when the preliminary results were first made available but not yet peer-reviewed and not yet published there was a huge Fiasco huge press announcement about it suggesting that the women receiving the Cee plus MPA in the uh group of the uterus had a higher incidence of breast cancer and that basically became the headline that never went away though it turned out not to be true let's talk about the numbers what was the increase in the risk of breast cancer in that group which gets to my one of my if you know if you've ever listened to me on the podcast rail on something listen I have about 3 800 Pet Peeves and counting my laboratory staff know these um know a good number of them so I do not have to apologize for having many pet peeves because as long as they have experience in data to support them it provides so one of my biggest pet peeves is and my my team knows this because sometimes they'll occasionally you know they'll do this and I'll have to remind them you never talk about a relative risk change without an absolute risk accommodating it right so so what does that look like so the the relative risk increase of breast cancer in the estrogen plus MPA group versus the placebo was 25 27 percent and that became the only headline HRT increases risk of breast cancer by 27 percent now",
        "start": "00:12:28",
        "duration": 224.9999999999999,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "I don't think that's true at all today but let's even look at the data what was the ARR what was the absolute risk increase it was a difference between five cases per thousand and four cases per thousand so the ARR was 0.1 percent one case in a thousand and it's true going from four and a thousand to five in a thousand is a 25 increase but it's a completely inappropriate context I agree and I feel like headlines of that sort which have come up recently around various dietary interventions we won't go there at least we're not for the time being um are nothing short of criminal because they really distort people's thinking but also they steer the course of science and medicine for as you pointed out for decades if not longer and they can really take us off our health track in serious ways so I'll bring this Meandering to a close which is to say even though I could spend the next hour talking about all of the ways in which this study was flawed and all of the very unethical things that were done by a number of the investigators who went out of their way to mask the truth of this study from the world I'll tell a woman today we're going to start you on this when you're going through menopause we're using bioidentical hormones and if you're upper bound risk of breast cancer is one one case in a thousand you should at least weigh that against all of the other benefits which I'll talk about now there's something else I want to say because a moment ago I alluded to the fact that I think the mpa might have been the biggest issue in that study so there were two findings in that study that were negative one was the in small increase in the risk of heart disease",
        "start": "00:14:20",
        "duration": 214.50000000000003,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "and the small increase in the risk of breast cancer but consider the other group we forgot about the group that didn't have a uterus because remember those women got estrogen only versus placebo what was the difference in breast cancer there well this is interesting because it didn't reach statistical significance but its p-value was 0.06 or 0.07 so it came very close but it was in the opposite direction it was a 24 risk reduction about one in a thousand as well so when you had estrogen plus MPA you had a barely statistically significant the p-value was 0.05 so it just hit statistical significance one in a thousand cases for breast cancer and then you had one in a thousand cases but p-value of 0.07 for reduction of risk of breast cancer which to me suggests that the mpa the synthetic progesterone was playing more of a role than anything else the second thing I point out is oral estrogen which we no longer use does increase coagulability it does increase the ability of the blood to clot a little bit and when we look at the more recent data on HRT using topical estrogen or patches of estrogen we don't see that at all in fact we see the opposite now so now we see the risk of heart disease going down in women with estradiol and some women will be arriving to those treatments with mutations and things like Factor five Leiden and other clotting factors is it appropriate to say that everyone both male and female should know whether or not they have mutant forms of factor five Leiden you know we don't typically test people for Factor five my wife actually has it but we didn't learn it until she had help syndrome giving birth to our first daughter um but um you know we kind of look for more family history reason to be testing",
        "start": "00:16:07",
        "duration": 220.38099999999991,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "things like that we take a pretty detailed family history so we'll kind of look for clotting issues there what about um so your reflex nowadays is to put women on these topical questions basically have the discussion right so so here's where we still struggle right is you know we if it were up to me I'd prefer for a woman's um HRT to be provided by her GYN because we want to be able to work in partnership with the GYN who we would like to see an endometrial ultrasound done every year um that's you know some would argue that's Overkill but you know we think she'd be sharing a pap smear every year as well so if we're looking at the cervix we want to look at the endometrium we want to make sure the lining isn't too thick the other thing I should say Andrew is today we now realize that not all women can tolerate pardon me progesterone so you have to be careful so assuming again a woman still has her uterus the estrogen solves most of the problems but then you have to decide can she tolerate the progesterone and it needs to be if given systemically like 100 to 200 milligrams and for some women that is a life-saving intervention I mean they start sleeping better their hair gets thicker they feel better but for some women it literally drives them crazy it's probably the reciprocal of what we were seeing in the case of women with PMS so in those situations we say great we're done with oral progesterone we just use a progesterone coated IUD so then you get the local progesterone in the uterus for protection and the systemic estrogen fascinating what about um oral contraception um for in women uh so the use of estrogen chronically through equals you know college Years or the 20s 30s maybe",
        "start": "00:17:58",
        "duration": 207.419,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "even teens who knows um what's known about the long-term effects if any I gotta be honest I don't I don't think I know enough to comment on it it's not it's not something that really impacts my patient population um you know at least in what I see more women are using iuds for uh for for contraception than OCS I mean we use OCS sometimes in women who are pre-menopausal for symptomatic control but will typically use like a Lolo Estrin so a very low synthetic estrogen which I don't like using these very much but if it's the only thing we can get to control certain symptoms and we'll use it like half her cycle um but it's typically not something we're that experienced with what about testosterone because you mentioned that you know nanogram um per mil uh when you set everything to the same um you know I guess it's nanogram per deciliter as it would be to to kind of normalize everything right yeah and so yeah that's what Peter pointing out before is that you look at your charts and they're all in these different measures and so when you normalize testosterone is actually the higher than estrogen in women that's a surprise to me um do you prescribe testosterone therapy to women ever we do sometimes but I do it with much more caution because I don't have the data right so where I'll you know what we'll say is look I mean we're now really outside of an area where I can point to a lot of data like when it comes to estrogen and progesterone I'll I'll happily go toe-to-toe with anybody who wants to make the case that it's dangerous uh similarly when it comes to using testosterone in men I'll I'll spend all day and I can go through that literature until the other person cries and wants to just call Uncle right when it comes to you prescribe them",
        "start": "00:19:41",
        "duration": 213.77900000000005,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    },
    {
        "text": "testosterone when it comes to estrogen and testosterone in women don't have that data and I'd love to see that trial done so how what's the what's the Sweet Spot how do we how do we reconcile that so it's not something I consider standard and basically if a woman is for testosterone first of all is staggeringly low and again even though her testosterone is low compared to a male we still have a range so if it's really at the bottom of that range she's really having difficulty putting on muscle mass and really complaining of low libido I think in that situation we'll go ahead and use topical testosterone um and and you know replace her to a level that is still physiologically normal yeah that's key because when people hear HRT they think about super physiological seems to be the term yeah like I've never seen a single symptom in a single woman that I've put testosterone on in terms of like acne body hair things like that like those are real symptoms that you have to be aware of but you know like clitoral enlargement and things like that like that doesn't happen under physiologic normal conditions",
        "start": "00:21:28",
        "duration": 126.46199999999999,
        "title": "Menstruation, Menopause, and Hormone Replacement Therapy for Women"
    }
]